Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.15 | $-0.18 | 16.7 % |
Jun 2024 | 2024-08-12 | $-0.05 | $-0.15 | 66.7 % |
Mar 2024 | 2024-05-07 | $0.34 | $0.05 | 580.0 % |
Dec 2023 | 2024-02-27 | $-0.50 | $-0.48 | -4.17 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $51.63M | $51.32M | 0.61 % |
Jun 2024 | 2024-08-12 | $73.83M | $50.59M | 46.0 % |
Mar 2024 | 2024-05-07 | $137.74M | $84.51M | 63.0 % |
Dec 2023 | 2024-02-27 | $32.25M | $28.70M | 12.4 % |
Esperion Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
Esperion Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.15, which beat the estimate of $-0.18.
Esperion Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.